INTRODUCTION: The proportion of women being treated with biologics is growing. However, data on treatment recommendation awareness among treating physicians and women who are considering pregnancy and family planning are limited. In this study, we used a questionnaire survey to learn how rheumatologists and dermatologists address women's needs for family planning, pregnancy, and breastfeeding, as well as their possible concerns with concurrent inflammatory rheumatic disease or psoriasis. METHODS: A 55-question (in English) survey aimed at identifying surveyed physicians' current practices regarding the reproductive health needs of women with rheumatoid arthritis, psoriasis, or psoriatic arthritis. This survey included 82 rheumatologists and 38 dermatologists from the Czech Republic, Hungary, and Slovakia. RESULTS: The proportion of female patients of reproductive age with the moderate-to-severe disease was 10-30% of all patients treated by the respondents. At the time of diagnosis, approximately two-thirds of the respondents discussed family planning with their patients. Rheumatologists collaborated with other specialists more frequently than dermatologists and gynecologist-obstetricians. Half of the rheumatologists revised systemic treatment 6 months before the patient planned to become pregnant, whereas dermatologists appear to act much sooner. Rheumatologists chose systemic glucocorticoids as the first-line treatment for pregnancy flares, whereas dermatologists chose topical corticosteroids. Congresses and interdisciplinary forums were rated the most valuable sources of information by physicians. CONCLUSIONS: There is a need for more holistic, multidisciplinary, collaborative, and integrated communication between clinicians and women of childbearing age. Physicians should consider the implications of these conditions and medical treatment for women of childbearing age and family planning for those with rheumatoid arthritis and psoriatic disease. Patient-centered care that includes patients' reproductive choices should be a routine clinical practice.

1st Department of Internal Medicine Faculty of Medicine Pavol Jozef Šafárik University in Košice Košice Slovakia

Department of Dermatovenerology 3rd Faculty of Medicine Charles University and Královské Vinohrady University Hospital Prague Czech Republic

Faculty of Medicine of the University of Debrecen Debrecen Hungary

Institute of Rheumatology Na Slupi 4 128 00 Praha Czech Republic

PHARMICO a s Brno Czech Republic

Rheumatology 2nd Department of Internal Medicine Faculty of Medicine of Masaryk University and St Anne's University Hospital in Brno Anny Brno Czech Republic

Zobrazit více v PubMed

van Vollenhoven RF. Sex differences in rheumatoid arthritis: more than meets the eye. BMC Med. 2009;7:12. doi: 10.1186/1741-7015-7-12. PubMed DOI PMC

Skomsvoll JF, Ostensen M, Baste V, Irgens LM. Number of births, interpregnancy interval, and subsequent pregnancy rate after a diagnosis of inflammatory rheumatic disease in Norwegian women. J Rheumatol. 2001;28:2310–2314. PubMed

Jawaheer D, Zhu JL, Nohr EA, Olsen J. Time to pregnancy among women with rheumatoid arthritis. Arthritis Rheum. 2011;63:1517–1521. doi: 10.1002/art.30327. PubMed DOI PMC

Provost M, Eaton JL, Clowse ME. Fertility and infertility in rheumatoid arthritis. Curr Opin Rheumatol. 2014;26:308–314. doi: 10.1097/BOR.0000000000000058. PubMed DOI

Ackerman IN, Jordan JE, Van Doornum S, Ricardo M, Briggs AM. Understanding the information needs of women with rheumatoid arthritis concerning pregnancy, post-natal care and early parenting: a mixed-methods study. BMC Musculoskelet Disord. 2015;16:194. doi: 10.1186/s12891-015-0657-4. PubMed DOI PMC

Andreoli L, Lazzaroni MG, Carini C, et al. “Disease knowledge index” and perspectives on reproductive issues: a nationwide study on 398 women with autoimmune rheumatic diseases. Jt Bone Spine. 2019;86:475–481. doi: 10.1016/j.jbspin.2018.12.002. PubMed DOI

Carandang K, Mruk V, Ardoin SP, et al. Reproductive health needs of adolescent and young adult women with pediatric rheumatic diseases. Pediatr Rheumatol. 2020;18:66. doi: 10.1186/s12969-020-00460-7. PubMed DOI PMC

Chakravarty E, Clowse ME, Pushparajah DS, Mertens S, Gordon C. Family planning and pregnancy issues for women with systemic inflammatory diseases: patient and physician perspectives. BMJ Open. 2014;4:e004081. doi: 10.1136/bmjopen-2013-004081. PubMed DOI PMC

Chakravarty EF, Nelson L, Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 2006;54:899–907. doi: 10.1002/art.21663. PubMed DOI

Lin HC, Chen SF, Lin HC, Chen YH. Increased risk of adverse pregnancy outcomes in women with rheumatoid arthritis: a nationwide population-based study. Ann Rheum Dis. 2010;69:715–717. doi: 10.1136/ard.2008.105262. PubMed DOI

Wallenius M, Skomsvoll JF, Irgens LM, et al. Pregnancy and delivery in women with chronic inflammatory arthritides with a specific focus on first birth. Arthritis Rheum. 2011;63:1534–1542. doi: 10.1002/art.30210. PubMed DOI

Meeuwis KA, de Hullu JA, van de Nieuwenhof HP, et al. Quality of life and sexual health in patients with genital psoriasis. Br J Dermatol. 2011;164:1247–1255. doi: 10.1111/j.1365-2133.2011.10249.x. PubMed DOI

Kerschbaumer A, Fenzl KH, Erlacher L, Aletaha D. An overview of psoriatic arthritis—epidemiology, clinical features, pathophysiology and novel treatment targets. Wien Klin Wochenschr. 2016;128:791–795. doi: 10.1007/s00508-016-1111-9. PubMed DOI PMC

Murray K, Moore L, O’Brien C, et al. A multidisciplinary approach to reproductive healthcare in women with rheumatic disease. Ir J Med Sci. 2020;189:237–243. doi: 10.1007/s11845-019-02040-5. PubMed DOI

Østensen M. Management of early aggressive rheumatoid arthritis during pregnancy and lactation. Expert Opin Pharmacother. 2009;10:1469–1479. doi: 10.1517/14656560902980194. PubMed DOI

Gordon C. How does rheumatic disease affect family planning and pregnancy? Rheumatology. 2016;55:i22–i22.

Gottlieb AB, Ryan C, Murase JE. Clinical considerations for the management of psoriasis in women. Int J Womens Dermatol. 2019;5:141–150. doi: 10.1016/j.ijwd.2019.04.021. PubMed DOI PMC

Krause ML, Makol A. Management of rheumatoid arthritis during pregnancy: challenges and solutions. Open Access Rheumatol. 2016;8:23–36. PubMed PMC

Nelson-Piercy C, Vlaev I, Harris K, Fischer-Betz R. What factors could influence physicians’ management of women of childbearing age with chronic inflammatory disease? A systematic review of behavioural determinants of clinical inertia. BMC Health Serv Res. 2019;19:863. doi: 10.1186/s12913-019-4693-x. PubMed DOI PMC

Nast A, Smith C, et al. EuroGuiDerm guideline on the systemic treatment of psoriasis vulgaris—Part 2: specific clinical and comorbid situations. J Eur Acad Dermatol Venereol. 2021;35:281–317. doi: 10.1111/jdv.16926. PubMed DOI

Götestam Skorpen C, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75:795–810. doi: 10.1136/annrheumdis-2015-208840. PubMed DOI

Kavanaugh A, Cush JJ, Ahmed MS, Bermas BL, Chakravarty E, Chambers C. Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases. Arthritis Care Res (Hoboken) 2015;67:313–325. doi: 10.1002/acr.22516. PubMed DOI

Murase JE, De Simone C, Fischer-Betz R, Ecoffet C, Tincani A. Fears and misconceptions of women with chronic inflammatory diseases on their journey to motherhood. J Am Acad Dermatol. 2019;81(4, Suppl.1):AB65. doi: 10.1016/j.jaad.2019.06.265. DOI

Skorpen CG, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75:795–810. doi: 10.1136/annrheumdis-2015-208840. PubMed DOI

Flint J, Panchal S, Hurrell A, et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford) 2016;55:1693–1697. doi: 10.1093/rheumatology/kev404. PubMed DOI

Smeele HT, Röder E, Wintjes HM, Kranenburg-van Koppen LJ, Hazes JM, Dolhain RJ. Modern treatment approach results in low disease activity in 90% of pregnant rheumatoid arthritis patients: the PreCARA study. Ann Rheum Dis. 2021;80:859–864. doi: 10.1136/annrheumdis-2020-219547. PubMed DOI PMC

Wolgemuth T, Stransky OM, Chodoff A, et al. Exploring the preferences of women regarding sexual and reproductive health care in the context of rheumatology: a qualitative study. Arthritis Care Res. 2021;73:1194–1200. doi: 10.1002/acr.24249. PubMed DOI PMC

Añón-Oñate I, Cáliz-Cáliz R, Rosa-Garrido C, Pérez-Galán MJ, Quirosa-Flores S, Pancorbo-Hidalgo PL. Multidisciplinary unit improves pregnancy outcomes in women with rheumatic diseases and hereditary thrombophilias: an observational study. J Clin Med. 2021;10:1487. doi: 10.3390/jcm10071487. PubMed DOI PMC

Tincani A, Taylor P, Fischer-Betz R, EULAR et al. FRI0693 fears and misconceptions of women with chronic rheumatic diseases on their journey to motherhood. Ann Rheum Dis. 2018;2018(77):866.